These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19638691)

  • 21. [Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
    Iwashita Y; Iwashita Y; Ito T; Shigematsu T
    Clin Calcium; 2016 Feb; 26(2):259-67. PubMed ID: 26813506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The measurements of bone turnover].
    Kushida K; Takahashi M; Hoshino H
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():295-8. PubMed ID: 9097608
    [No Abstract]   [Full Text] [Related]  

  • 23. [Is bone biopsy necessary for the diagnosis of metabolic bone diseases? Non- invasive assessment of bone turn over markers could define the cause of metabolic bone diseases].
    Suzuki A
    Clin Calcium; 2011 Sep; 21(9):1393-6. PubMed ID: 21881203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease-mineral-bone disorder: a new paradigm.
    Moe SM; Drüeke T; Lameire N; Eknoyan G
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):3-12. PubMed ID: 17200038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).
    Manghat P; Souleimanova I; Cheung J; Wierzbicki AS; Harrington DJ; Shearer MJ; Chowienczyk P; Fogelman I; Nerlander M; Goldsmith D; Hampson G
    Bone; 2011 May; 48(5):1127-32. PubMed ID: 21281749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chronic kidney disease (CKD) and bone. The mechanisms of chronic kidney disease--mineral and bone disorder (CKD-MBD)].
    Hamada Y; Fukagawa M
    Clin Calcium; 2009 Apr; 19(4):486-92. PubMed ID: 19329826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder].
    Mizobuchi M; Aoshima Y; Akizawa T
    Clin Calcium; 2010 Jul; 20(7):995-1003. PubMed ID: 20585177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mineral and bone disturbances associated with chronic kidney disease].
    Suchowierska E; Myśliwiec M
    Pol Merkur Lekarski; 2010 Feb; 28(164):138-43. PubMed ID: 20369744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Atheroma and vascular calcification in hemodialysis patients].
    Joki N; Tanaka Y
    Clin Calcium; 2010 Jul; 20(7):1061-6. PubMed ID: 20585185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
    Nowak Z; Konieczna M; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
    Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone alkaline phosphatase in CKD-mineral bone disorder.
    Sardiwal S; Magnusson P; Goldsmith DJ; Lamb EJ
    Am J Kidney Dis; 2013 Oct; 62(4):810-22. PubMed ID: 23623575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
    Inaguma D; Tatematsu M
    Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Secondary osteoporosis UPDATE. Bone disease with decreased kidney function].
    Okuno S; Ishimura E
    Clin Calcium; 2010 May; 20(5):655-62. PubMed ID: 20445276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Kidney and bone update : the 5-year history and future of CKD-MBD. Progress in therapy of CKD-MBD with vitamin D receptor activators].
    Shoji T
    Clin Calcium; 2012 Jul; 22(7):1073-81. PubMed ID: 22750940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone histology in chronic kidney disease-related mineral and bone disorder.
    Kazama JJ
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():23-5. PubMed ID: 21595848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S; Inaba M; Kurajoh M; Shidara K; Imanishi Y; Ishimura E; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline].
    Tsukamoto Y
    Clin Calcium; 2010 Jul; 20(7):1021-7. PubMed ID: 20585180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markers of bone turnover: biochemical and clinical perspectives.
    Pagani F; Francucci CM; Moro L
    J Endocrinol Invest; 2005; 28(10 Suppl):8-13. PubMed ID: 16550716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.